Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study (Breast Cancer, (2022), 29, 1, (92-102), 10.1007/s12282-021-01283-4)

Su Jin Koh, Shozo Ohsumi, Masato Takahashi, Eisuke Fukuma, Kyung Hae Jung, Takanori Ishida, Ming Shen Dai, Chuan Hsun Chang, Tapashi Dalvi, Graham Walker, James Bennett, Joyce O’Shaughnessy, Judith Balmaña

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study (Breast Cancer, (2022), 29, 1, (92-102), 10.1007/s12282-021-01283-4)'. Together they form a unique fingerprint.

Medicine and Dentistry